H.R. 10254 — MORE Savings Act

This section requires the Center for Medicare and Medicaid Innovation to test a model eliminating coinsurance, copayments, and deductibles under Medicare parts B and D (including under part C) for drugs and biologicals to treat opioid use disorders or reverse overdose, behavioral health services for such disorders, and recovery support services such as peer counseling. The model must be implemented within six months of enactment in 15 states selected for high Medicare beneficiary populations, high opioid overdose death rates, and significant rural areas, and may not be terminated or modified during its first five years.

This section requires group health plans and health insurance issuers to cover, without cost-sharing, prescription drugs for opioid use disorder treatment or overdose reversal, behavioral health services including in licensed non-hospital residential facilities, and community recovery support services such as peer counseling and transportation when provided with medication-assisted treatment. The requirement applies to plan years beginning on or after January 1, 2027.

This section sets the federal medical assistance percentage at 90 percent for state expenditures on medication-assisted treatment for opioid use disorder in the 50 states and the District of Columbia. It also allows states to include recovery support services, such as peer counseling and transportation, as part of medication-assisted treatment.